{"version":"1.0","provider_name":"Visual Studio news feed","provider_url":"https:\/\/devblogs.microsoft.com\/vsnews","author_name":"App Center Team","author_url":"https:\/\/devblogs.microsoft.com\/vsnews\/akams-author\/aadsso-100030000fe84d86c\/","title":"Voronoi Selection for Cancer Drug Network Visualization in Mixed Reality","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"qtPWY773pm\"><a href=\"https:\/\/devblogs.microsoft.com\/vsnews\/akams-txdkkh\/\">Voronoi Selection for Cancer Drug Network Visualization in Mixed Reality<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/devblogs.microsoft.com\/vsnews\/akams-txdkkh\/embed\/#?secret=qtPWY773pm\" width=\"600\" height=\"338\" title=\"&#8220;Voronoi Selection for Cancer Drug Network Visualization in Mixed Reality&#8221; &#8212; Visual Studio news feed\" data-secret=\"qtPWY773pm\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/devblogs.microsoft.com\/vsnews\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","thumbnail_url":"https:\/\/devblogs.microsoft.com\/vsnews\/wp-content\/uploads\/sites\/25\/2018\/08\/vsfeaturebig.png","thumbnail_width":716,"thumbnail_height":448,"description":"Researchers at the Englander Institute for Precision Medicine (EIPM) at Weill Cornell Medicine bring together basic science, medicine, DNA sequencing and big data to deliver the next generation of precision medicine; it is the most promising approach to tackle diseases like cancer, neurodegenerative diseases, and rare genetic conditions that have thus far eluded effective treatments. [&hellip;]"}